Conflicts of interest
Naohiro Sekiguchi received research funds from Ono, A2 Healthcare, Astellas, Janssen, MSD, Otsuka, Pfizer, PPD-SNBL, Sumimoto Dainippon, Daiichi Sankyo, and Bristol Myers Squibb. Senji Kasahara received research funds from Daiichi Sankyo. Toshihiro Miyamoto received research funds from Daiichi Sankyo and speaker fees from Bristol Myers Squibb, Otsuka, MSD, Astellas, Astellas Amgen, Celgene, AbbVie, and Takeda. Toru Kiguchi received speaker fees from Bristol Myers Squibb and Novartis, as well as research funds from Bristol Myers Squibb, Daiichi Sankyo, Otsuka, MSD, Takeda, Astella, Nippon Shinyaku, Novartis, Sumimoto Dainippon, Janssen, SymBio, Celgene, and Sanofi. Hitoshi Ohno received research funds from Daiichi Sankyo. Taiga Takagi, Masaya Tachibana, Hiroyuki Sumi, Yasuyuki Kakurai, and Tomonari Yamashita are employees of Daiichi Sankyo. Kensuke Usuki received speaker fees from Novartis as well as research funds from Astellas, Alexion, AbbVie, Gilead, SymBio, Daiichi Sankyo, Sumimoto Dainippon, Chugai, Otsuka, Novartis, Bristol Myers Squibb, Takeda, Astellas Amgen, Apellis, and Nippon Shinyaku.